University of California-Los Angeles · PharmacologyWu Immunology Lab
Ting-Ting Wu · Los Angeles, California
Research Focus
Dr. Ting-Ting Wu's lab at UCLA focuses on developing an innovative vaccine for Kaposi sarcoma-associated herpesvirus (KSHV), a major cause of cancer in certain populations. The lab's research aims to enhance both the antibody and T cell responses to effectively protect against KSHV infections. By creating a vaccine that improves immunity in high-risk groups, the lab aims to reduce the incidence of KSHV-related diseases, particularly in resource-limited settings and among individuals with compromised immune systems.
KSHVvaccine developmentimmunologyT cell responseantibody responseHIVcancer preventionpublic healthvaccine design
Research Aims
3AIM 01Develop a KSHV vaccine that generates strong humoral antibody responses.
AIM 02Enhance T cell immunity against KSHV-infected cells using RNA adjuvants.
AIM 03Combine different vaccine strategies to stimulate robust immune responses.
Skills the Lab Values
vaccine designRNA-based adjuvantshumoral immunity techniquesT cell activation methodsimmunogen engineeringcell culturemolecular biology techniquesimmunological assays
Output against the department
Publications235top 35% of dept.162nd of 462
this lab
most publishedleast published
Citations5.3kbottom 39% of dept.284th of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.